Rare disease news, mapped to the diseases behind the headlines. AI-classified across pipeline, policy, funding, science, and community.
Be among the first to receive Kisho Intelligence Briefings
Showing news related to
Showing 1–1 of 1 stories
Recent research identifies mitochondrial energetic failure as a key factor in FLVCR1-related sensory neuropathy. This discovery could pave the way for targeted therapies addressing the underlying mitochondrial dysfunction.
Read full storyGet the week's most important rare disease developments — pipeline moves, policy changes, and funding signals — delivered to your inbox every Monday.
Free weekly briefing. Unsubscribe anytime.